MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025)
MeiraGTx Holdings (MGTX) posted Current Deferred Revenue of $1.8 million for Q4 2025, down 35.23% on a QoQ basis from $2.7 million in Q3 2025, and down 63.21% year-over-year from $4.8 million in Q4 2024.
MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025) Analysis & Trends
MeiraGTx Holdings' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $1.8 million for Q4 2025.
- Quarterly Current Deferred Revenue fell 63.21% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 63.21% YoY) and the FY2025 annual result came in at $1.8 million, down 63.21% from the prior year.
- Current Deferred Revenue was $1.8 million for Q4 2025 at MeiraGTx Holdings, down from $2.7 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $25.6 million in Q1 2021 and bottomed at $1.8 million in Q4 2025.
- A 5-year average of $11.8 million and a median of $10.0 million in 2023 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue plunged 80.65% — and 2024, when it jumped 64.97%.
- MeiraGTx Holdings' Current Deferred Revenue stood at $21.8 million in 2021, then plunged by 30.69% to $15.1 million in 2022, then plunged by 80.65% to $2.9 million in 2023, then soared by 64.97% to $4.8 million in 2024, then plunged by 63.21% to $1.8 million in 2025.
- Business Quant data shows MGTX's Current Deferred Revenue at $1.8 million in Q4 2025, $2.7 million in Q3 2025, and $2.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 13.69 Mn |
| Dec 31, 2022 | 15.12 Mn |
| Sep 30, 2022 | 18.88 Mn |
| Jun 30, 2022 | 21.21 Mn |
| Mar 31, 2022 | 20.19 Mn |
| Dec 31, 2021 | 21.82 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 24.88 Mn |
| Mar 31, 2021 | 25.60 Mn |